Author | Nikhil Khushalani, MD | OncLive

Author | Nikhil Khushalani, MD

Articles

Dr. Khushalani on Goals for the CA045-001 Trial in Melanoma

July 25, 2019

Video

Nikhil Khushalani, MD, vice chair, Department of Cutaneous Oncology, Moffitt Cancer Center, discusses the plans for the CA045-001 trial, an international, multicenter study that is comparing bempegaldesleukin plus nivolumab versus nivolumab monotherapy in patients with previously untreated, unresectable, or metastatic melanoma.

Dr. Khushalani on Reasoning for the CA045-001 Trial

July 09, 2019

Video

Nikhil Khushalani, MD, discusses the CA045-001 study, a phase III, randomized study that compared bempegaldesleukin plus nivolumab versus nivolumab monotherapy in patients with previously untreated, unresectable, or metastatic melanoma.

x